In this report, we described a case of synchronous bilateral lung cancers with EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ in the left, which was EML4-ALK negative. This evidence concerns the gene ALK and adenocarcinoma in situ.